nodes	percent_of_prediction	percent_of_DWPC	metapath
Droperidol—Fenbufen—PTGS2—melanoma	0.00669	0.427	CrCbGaD
Droperidol—Altered state of consciousness—Temozolomide—melanoma	0.00633	0.0717	CcSEcCtD
Droperidol—Extrapyramidal disorder—Temozolomide—melanoma	0.00388	0.044	CcSEcCtD
Droperidol—Domperidone—ABCB1—melanoma	0.00346	0.221	CrCbGaD
Droperidol—Amenorrhoea—Temozolomide—melanoma	0.00333	0.0377	CcSEcCtD
Droperidol—Pimozide—ABCB1—melanoma	0.00289	0.184	CrCbGaD
Droperidol—Gynaecomastia—Carmustine—melanoma	0.00271	0.0307	CcSEcCtD
Droperidol—Haloperidol—ABCB1—melanoma	0.00264	0.168	CrCbGaD
Droperidol—Chills—Vemurafenib—melanoma	0.00258	0.0292	CcSEcCtD
Droperidol—Amenorrhoea—Docetaxel—melanoma	0.00221	0.0251	CcSEcCtD
Droperidol—Bronchospasm—Bleomycin—melanoma	0.00214	0.0242	CcSEcCtD
Droperidol—Anaphylactic shock—Vemurafenib—melanoma	0.00204	0.0231	CcSEcCtD
Droperidol—Blood pressure increased—Docetaxel—melanoma	0.00194	0.022	CcSEcCtD
Droperidol—Hypotension—Vemurafenib—melanoma	0.00191	0.0216	CcSEcCtD
Droperidol—Hyperglycaemia—Carmustine—melanoma	0.00171	0.0194	CcSEcCtD
Droperidol—Depression—Carmustine—melanoma	0.00169	0.0191	CcSEcCtD
Droperidol—Hyperglycaemia—Temozolomide—melanoma	0.00165	0.0187	CcSEcCtD
Droperidol—Depression—Temozolomide—melanoma	0.00163	0.0185	CcSEcCtD
Droperidol—Body temperature increased—Vemurafenib—melanoma	0.00161	0.0183	CcSEcCtD
Droperidol—Chills—Bleomycin—melanoma	0.00156	0.0177	CcSEcCtD
Droperidol—Hallucination—Carmustine—melanoma	0.00151	0.0171	CcSEcCtD
Droperidol—Hypersensitivity—Vemurafenib—melanoma	0.0015	0.017	CcSEcCtD
Droperidol—Hallucination—Temozolomide—melanoma	0.00146	0.0165	CcSEcCtD
Droperidol—Chills—Dactinomycin—melanoma	0.00146	0.0165	CcSEcCtD
Droperidol—Dizziness—Vemurafenib—melanoma	0.00135	0.0153	CcSEcCtD
Droperidol—Chills—Temozolomide—melanoma	0.00132	0.0149	CcSEcCtD
Droperidol—Rash—Vemurafenib—melanoma	0.00129	0.0146	CcSEcCtD
Droperidol—Dermatitis—Vemurafenib—melanoma	0.00129	0.0146	CcSEcCtD
Droperidol—Anaphylactic shock—Bleomycin—melanoma	0.00124	0.014	CcSEcCtD
Droperidol—Bronchospasm—Docetaxel—melanoma	0.0012	0.0136	CcSEcCtD
Droperidol—Angioedema—Temozolomide—melanoma	0.00117	0.0132	CcSEcCtD
Droperidol—Hypotension—Bleomycin—melanoma	0.00116	0.0131	CcSEcCtD
Droperidol—Hypertension—Carmustine—melanoma	0.00114	0.0129	CcSEcCtD
Droperidol—Palpitations—Temozolomide—melanoma	0.00113	0.0128	CcSEcCtD
Droperidol—Anxiety—Carmustine—melanoma	0.00112	0.0127	CcSEcCtD
Droperidol—Hypertension—Temozolomide—melanoma	0.0011	0.0125	CcSEcCtD
Droperidol—Anxiety—Temozolomide—melanoma	0.00108	0.0123	CcSEcCtD
Droperidol—Tachycardia—Carmustine—melanoma	0.00105	0.0119	CcSEcCtD
Droperidol—Anaphylactic shock—Temozolomide—melanoma	0.00104	0.0118	CcSEcCtD
Droperidol—Hypotension—Carmustine—melanoma	0.00101	0.0114	CcSEcCtD
Droperidol—Body temperature increased—Bleomycin—melanoma	0.000977	0.0111	CcSEcCtD
Droperidol—Somnolence—Carmustine—melanoma	0.000959	0.0109	CcSEcCtD
Droperidol—Somnolence—Temozolomide—melanoma	0.000927	0.0105	CcSEcCtD
Droperidol—Body temperature increased—Dactinomycin—melanoma	0.000911	0.0103	CcSEcCtD
Droperidol—Hypersensitivity—Bleomycin—melanoma	0.000911	0.0103	CcSEcCtD
Droperidol—Chills—Docetaxel—melanoma	0.000876	0.00992	CcSEcCtD
Droperidol—Body temperature increased—Carmustine—melanoma	0.000853	0.00967	CcSEcCtD
Droperidol—Hypersensitivity—Dactinomycin—melanoma	0.00085	0.00963	CcSEcCtD
Droperidol—Body temperature increased—Temozolomide—melanoma	0.000824	0.00934	CcSEcCtD
Droperidol—Hypersensitivity—Carmustine—melanoma	0.000795	0.00901	CcSEcCtD
Droperidol—Rash—Bleomycin—melanoma	0.00078	0.00883	CcSEcCtD
Droperidol—Dermatitis—Bleomycin—melanoma	0.000779	0.00882	CcSEcCtD
Droperidol—Hypersensitivity—Temozolomide—melanoma	0.000768	0.00871	CcSEcCtD
Droperidol—Syncope—Docetaxel—melanoma	0.000762	0.00863	CcSEcCtD
Droperidol—Palpitations—Docetaxel—melanoma	0.000751	0.00851	CcSEcCtD
Droperidol—Loss of consciousness—Docetaxel—melanoma	0.000747	0.00846	CcSEcCtD
Droperidol—Hypertension—Docetaxel—melanoma	0.000734	0.00831	CcSEcCtD
Droperidol—Rash—Dactinomycin—melanoma	0.000727	0.00824	CcSEcCtD
Droperidol—Dizziness—Carmustine—melanoma	0.000714	0.00809	CcSEcCtD
Droperidol—Anaphylactic shock—Docetaxel—melanoma	0.000694	0.00786	CcSEcCtD
Droperidol—Dizziness—Temozolomide—melanoma	0.00069	0.00781	CcSEcCtD
Droperidol—Shock—Docetaxel—melanoma	0.000682	0.00773	CcSEcCtD
Droperidol—Rash—Carmustine—melanoma	0.00068	0.00771	CcSEcCtD
Droperidol—Dermatitis—Carmustine—melanoma	0.00068	0.0077	CcSEcCtD
Droperidol—Tachycardia—Docetaxel—melanoma	0.000677	0.00767	CcSEcCtD
Droperidol—Rash—Temozolomide—melanoma	0.000658	0.00745	CcSEcCtD
Droperidol—Dermatitis—Temozolomide—melanoma	0.000657	0.00744	CcSEcCtD
Droperidol—Hypotension—Docetaxel—melanoma	0.000648	0.00734	CcSEcCtD
Droperidol—Somnolence—Docetaxel—melanoma	0.000617	0.00699	CcSEcCtD
Droperidol—Body temperature increased—Docetaxel—melanoma	0.000548	0.00621	CcSEcCtD
Droperidol—Hypersensitivity—Docetaxel—melanoma	0.000511	0.00579	CcSEcCtD
Droperidol—Dizziness—Docetaxel—melanoma	0.000459	0.0052	CcSEcCtD
Droperidol—Rash—Docetaxel—melanoma	0.000437	0.00495	CcSEcCtD
Droperidol—Dermatitis—Docetaxel—melanoma	0.000437	0.00495	CcSEcCtD
Droperidol—HTR2A—Signaling Pathways—FOXO4—melanoma	0.000275	0.000307	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCR4—melanoma	0.000275	0.000307	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—GNAQ—melanoma	0.000272	0.000304	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HDAC2—melanoma	0.00027	0.000301	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FOXO4—melanoma	0.00027	0.000301	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCR4—melanoma	0.00027	0.000301	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—GNAQ—melanoma	0.000267	0.000297	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CG—melanoma	0.000267	0.000297	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CG—melanoma	0.000262	0.000293	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SYK—melanoma	0.00026	0.00029	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3CD—melanoma	0.000258	0.000288	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CG—melanoma	0.000257	0.000287	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SYK—melanoma	0.000256	0.000286	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NGFR—melanoma	0.000255	0.000285	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ITGAV—melanoma	0.000255	0.000285	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT3—melanoma	0.000255	0.000285	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3CD—melanoma	0.000254	0.000283	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NGFR—melanoma	0.000251	0.00028	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ITGAV—melanoma	0.000251	0.00028	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT3—melanoma	0.000251	0.00028	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SYK—melanoma	0.000251	0.00028	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3CD—melanoma	0.000249	0.000277	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NGFR—melanoma	0.000246	0.000275	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ITGAV—melanoma	0.000246	0.000275	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT3—melanoma	0.000246	0.000275	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SOCS1—melanoma	0.000236	0.000264	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—MAP2K1—melanoma	0.000236	0.000263	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—S100B—melanoma	0.000236	0.000263	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CD—melanoma	0.000234	0.000262	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SOCS1—melanoma	0.000233	0.00026	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—MAP2K1—melanoma	0.000232	0.000259	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—S100B—melanoma	0.000232	0.000259	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CD—melanoma	0.000231	0.000257	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SOCS1—melanoma	0.000228	0.000254	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—MAP2K1—melanoma	0.000227	0.000254	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—S100B—melanoma	0.000227	0.000254	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CD—melanoma	0.000226	0.000252	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ERBB4—melanoma	0.000226	0.000252	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3CB—melanoma	0.000225	0.000251	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CDKN2B—melanoma	0.000224	0.00025	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ERBB4—melanoma	0.000222	0.000248	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3CB—melanoma	0.000221	0.000247	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CDKN2B—melanoma	0.00022	0.000246	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ERBB4—melanoma	0.000217	0.000243	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3CB—melanoma	0.000217	0.000242	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CD86—melanoma	0.000216	0.000241	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—CXCL8—melanoma	0.000216	0.000241	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CDKN2B—melanoma	0.000215	0.00024	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EDN1—melanoma	0.000215	0.000239	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CD86—melanoma	0.000213	0.000237	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—CXCL8—melanoma	0.000213	0.000237	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EDN1—melanoma	0.000211	0.000236	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGF1—melanoma	0.00021	0.000234	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CSF2—melanoma	0.00021	0.000234	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CD86—melanoma	0.000208	0.000233	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—CXCL8—melanoma	0.000208	0.000232	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EDN1—melanoma	0.000207	0.000231	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—IL2—melanoma	0.000207	0.000231	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGF1—melanoma	0.000206	0.00023	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CSF2—melanoma	0.000206	0.00023	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—E2F1—melanoma	0.000205	0.000229	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CB—melanoma	0.000204	0.000228	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—IL2—melanoma	0.000203	0.000227	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PDGFRA—melanoma	0.000203	0.000227	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGF1—melanoma	0.000202	0.000225	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CSF2—melanoma	0.000202	0.000225	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—E2F1—melanoma	0.000202	0.000225	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PRKCA—melanoma	0.000201	0.000224	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ITGB3—melanoma	0.000201	0.000224	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CB—melanoma	0.000201	0.000224	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PDGFRA—melanoma	0.0002	0.000223	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—IL2—melanoma	0.000199	0.000222	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ITGB3—melanoma	0.000198	0.000221	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PRKCA—melanoma	0.000198	0.000221	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—E2F1—melanoma	0.000198	0.000221	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—SPP1—melanoma	0.000197	0.00022	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CB—melanoma	0.000197	0.00022	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAP2K2—melanoma	0.000197	0.000219	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—CXCL8—melanoma	0.000196	0.000219	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PDGFRA—melanoma	0.000196	0.000218	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—SPP1—melanoma	0.000194	0.000216	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ITGB3—melanoma	0.000194	0.000216	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PRKCA—melanoma	0.000194	0.000216	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAP2K2—melanoma	0.000193	0.000216	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—CXCL8—melanoma	0.000193	0.000216	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—SPP1—melanoma	0.00019	0.000212	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAP2K2—melanoma	0.000189	0.000211	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—CXCL8—melanoma	0.000189	0.000211	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL2—melanoma	0.000188	0.000209	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TERT—melanoma	0.000187	0.000209	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—RAC1—melanoma	0.000186	0.000208	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL2—melanoma	0.000185	0.000206	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TERT—melanoma	0.000184	0.000205	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—RAC1—melanoma	0.000183	0.000205	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL2—melanoma	0.000181	0.000202	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TERT—melanoma	0.00018	0.000201	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—RAC1—melanoma	0.00018	0.0002	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HIF1A—melanoma	0.000179	0.000199	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HIF1A—melanoma	0.000176	0.000196	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HIF1A—melanoma	0.000172	0.000192	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KDR—melanoma	0.000171	0.000191	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KDR—melanoma	0.000168	0.000188	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KDR—melanoma	0.000165	0.000184	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FN1—melanoma	0.000165	0.000184	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FN1—melanoma	0.000162	0.000181	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NOTCH1—melanoma	0.000161	0.00018	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FN1—melanoma	0.000159	0.000177	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NOTCH1—melanoma	0.000158	0.000177	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CD80—melanoma	0.000158	0.000176	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CG—melanoma	0.000157	0.000176	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—APC—melanoma	0.000157	0.000176	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KIT—melanoma	0.000157	0.000176	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—NRAS—melanoma	0.000157	0.000176	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EGF—melanoma	0.000156	0.000174	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CD80—melanoma	0.000155	0.000173	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NOTCH1—melanoma	0.000155	0.000173	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—APC—melanoma	0.000155	0.000173	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KIT—melanoma	0.000155	0.000173	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CG—melanoma	0.000155	0.000173	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—NRAS—melanoma	0.000155	0.000173	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EGF—melanoma	0.000153	0.000171	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CD80—melanoma	0.000152	0.00017	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CG—melanoma	0.000152	0.000169	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KIT—melanoma	0.000152	0.000169	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—APC—melanoma	0.000152	0.000169	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—NRAS—melanoma	0.000152	0.000169	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—MAPK3—melanoma	0.000151	0.000168	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EGF—melanoma	0.00015	0.000167	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—MAPK3—melanoma	0.000148	0.000166	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—BRAF—melanoma	0.000148	0.000165	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—BRAF—melanoma	0.000146	0.000163	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—MAPK3—melanoma	0.000145	0.000162	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IGF1—melanoma	0.000144	0.000161	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—MAPK1—melanoma	0.000143	0.00016	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—EGFR—melanoma	0.000143	0.00016	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—BRAF—melanoma	0.000143	0.000159	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IGF1—melanoma	0.000142	0.000158	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—MAPK1—melanoma	0.000141	0.000158	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—EGFR—melanoma	0.000141	0.000158	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAP2K1—melanoma	0.000139	0.000156	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IGF1—melanoma	0.000139	0.000155	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CD—melanoma	0.000138	0.000154	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—MAPK1—melanoma	0.000138	0.000154	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—EGFR—melanoma	0.000138	0.000154	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—PIK3CA—melanoma	0.000137	0.000153	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAP2K1—melanoma	0.000137	0.000153	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CD—melanoma	0.000136	0.000152	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—KRAS—melanoma	0.000136	0.000151	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—PIK3CA—melanoma	0.000135	0.000151	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAP2K1—melanoma	0.000134	0.00015	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CD—melanoma	0.000133	0.000149	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—KRAS—melanoma	0.000133	0.000149	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—FGF2—melanoma	0.000133	0.000148	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—PIK3CA—melanoma	0.000132	0.000147	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—KRAS—melanoma	0.000131	0.000146	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—FGF2—melanoma	0.00013	0.000146	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—FGF2—melanoma	0.000128	0.000143	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—PIK3CA—melanoma	0.000125	0.000139	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MDM2—melanoma	0.000124	0.000138	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—PIK3CA—melanoma	0.000123	0.000137	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—ERBB2—melanoma	0.000122	0.000136	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MDM2—melanoma	0.000122	0.000136	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CB—melanoma	0.000121	0.000135	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—ERBB2—melanoma	0.00012	0.000134	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—PIK3CA—melanoma	0.00012	0.000134	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MDM2—melanoma	0.000119	0.000133	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CB—melanoma	0.000119	0.000132	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—ERBB2—melanoma	0.000118	0.000131	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CB—melanoma	0.000116	0.00013	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CXCL8—melanoma	0.000116	0.000129	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—HRAS—melanoma	0.000115	0.000129	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CXCL8—melanoma	0.000114	0.000127	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—HRAS—melanoma	0.000113	0.000126	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CDKN1B—melanoma	0.000113	0.000126	CbGpPWpGaD
Droperidol—DRD2—GPCR downstream signaling—AKT1—melanoma	0.000112	0.000125	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CXCL8—melanoma	0.000112	0.000125	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CDKN1B—melanoma	0.000111	0.000124	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—HRAS—melanoma	0.000111	0.000124	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CASP3—melanoma	0.000111	0.000124	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL2—melanoma	0.000111	0.000124	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—IL6—melanoma	0.00011	0.000123	CbGpPWpGaD
Droperidol—HTR2A—GPCR downstream signaling—AKT1—melanoma	0.00011	0.000123	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CASP3—melanoma	0.000109	0.000122	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CDKN1B—melanoma	0.000109	0.000122	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL2—melanoma	0.000109	0.000122	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—IL6—melanoma	0.000108	0.000121	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CCND1—melanoma	0.000108	0.000121	CbGpPWpGaD
Droperidol—ADRA1A—GPCR downstream signaling—AKT1—melanoma	0.000108	0.00012	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CTNNB1—melanoma	0.000107	0.000119	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CASP3—melanoma	0.000107	0.000119	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL2—melanoma	0.000107	0.000119	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CCND1—melanoma	0.000106	0.000119	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—IL6—melanoma	0.000106	0.000119	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CTNNB1—melanoma	0.000105	0.000117	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MMP9—melanoma	0.000105	0.000117	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—CDKN1A—melanoma	0.000104	0.000117	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PTEN—melanoma	0.000104	0.000116	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CCND1—melanoma	0.000104	0.000116	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NFKB1—melanoma	0.000104	0.000116	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MMP9—melanoma	0.000103	0.000115	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CTNNB1—melanoma	0.000103	0.000115	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—CDKN1A—melanoma	0.000103	0.000115	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PTEN—melanoma	0.000103	0.000114	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NFKB1—melanoma	0.000102	0.000114	CbGpPWpGaD
Droperidol—DRD2—Signaling by GPCR—AKT1—melanoma	0.000102	0.000114	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MMP9—melanoma	0.000101	0.000113	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—CDKN1A—melanoma	0.000101	0.000112	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PTEN—melanoma	0.0001	0.000112	CbGpPWpGaD
Droperidol—HTR2A—Signaling by GPCR—AKT1—melanoma	0.0001	0.000112	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NFKB1—melanoma	0.0001	0.000112	CbGpPWpGaD
Droperidol—ADRA1A—Signaling by GPCR—AKT1—melanoma	9.8e-05	0.000109	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—VEGFA—melanoma	9.42e-05	0.000105	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—STAT3—melanoma	9.32e-05	0.000104	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—NRAS—melanoma	9.3e-05	0.000104	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—VEGFA—melanoma	9.27e-05	0.000103	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—STAT3—melanoma	9.17e-05	0.000102	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—NRAS—melanoma	9.15e-05	0.000102	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—VEGFA—melanoma	9.07e-05	0.000101	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—STAT3—melanoma	8.98e-05	0.0001	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—NRAS—melanoma	8.96e-05	0.0001	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAPK3—melanoma	8.91e-05	9.94e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAPK3—melanoma	8.77e-05	9.78e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MYC—melanoma	8.66e-05	9.67e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAPK3—melanoma	8.58e-05	9.58e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MYC—melanoma	8.53e-05	9.51e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—MAPK1—melanoma	8.48e-05	9.46e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—EGFR—melanoma	8.47e-05	9.46e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MYC—melanoma	8.35e-05	9.32e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—MAPK1—melanoma	8.34e-05	9.31e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—EGFR—melanoma	8.34e-05	9.31e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—MAPK1—melanoma	8.17e-05	9.11e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—EGFR—melanoma	8.17e-05	9.11e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—KRAS—melanoma	8.01e-05	8.93e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—KRAS—melanoma	7.88e-05	8.79e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—KRAS—melanoma	7.71e-05	8.61e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—PIK3CA—melanoma	7.36e-05	8.21e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—PIK3CA—melanoma	7.24e-05	8.08e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—TP53—melanoma	7.12e-05	7.94e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—PIK3CA—melanoma	7.09e-05	7.91e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—TP53—melanoma	7e-05	7.81e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—TP53—melanoma	6.86e-05	7.65e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—HRAS—melanoma	6.81e-05	7.59e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—HRAS—melanoma	6.7e-05	7.47e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—HRAS—melanoma	6.56e-05	7.32e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—IL6—melanoma	6.51e-05	7.27e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—IL6—melanoma	6.41e-05	7.15e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—IL6—melanoma	6.28e-05	7e-05	CbGpPWpGaD
Droperidol—DRD2—Signaling Pathways—AKT1—melanoma	6.01e-05	6.71e-05	CbGpPWpGaD
Droperidol—HTR2A—Signaling Pathways—AKT1—melanoma	5.91e-05	6.6e-05	CbGpPWpGaD
Droperidol—ADRA1A—Signaling Pathways—AKT1—melanoma	5.79e-05	6.46e-05	CbGpPWpGaD
